A process is described in which a lactone ##STR1## is reacted with an alkylester X.sup.1 --CH.sub.2 and an oxidizing or dehydrogenating agent to form the phenol ester ##STR2##
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
申请人:AMGEN INC.
公开号:US20180177767A1
公开(公告)日:2018-06-28
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.